Wellmedr vs Embody: Pricing, shipping, and plan differences

Wellmedr vs Embody answers: Wellmedr emphasizes lifetime locked-in pricing, dose stability, and a money back guarantee, while Embody emphasizes the lowest entry price and 1 to 2 day free shipping. Early verdict: choose Wellmedr if you want locked pricing and promotional guarantees; choose Embody if your priority is the lowest advertised monthly price and fastest shipping.

See Wellmedr plans and pricing

Head-to-head overview: what each provider highlights

This comparison focuses on five supported differences: starting price and promotions, pricing model and guarantees, shipping speed and fulfillment, compounded medication and regulatory notices, and availability of branded options or plan types. All statements below reflect the supplied source evidence.

Starting price and promotional offers

Embody advertises the lowest entry price with compounded semaglutide at $69/month and tirzepatide at $119/month. The Embody listing notes the $69 semaglutide price was previously $299 and may be a limited-time offer. Wellmedr lists semaglutide from $89/month and highlights a Labor Day sale messaging and additional promotional language such as locking in $200 off every month or $49/mo on 12/month plans for life in captured landing-page evidence.

Pricing model, locked pricing, and guarantees

Wellmedr emphasizes lifetime locked-in pricing, no dose-based price increases, and a money back guarantee claiming a 100% refund if you do not lose weight in 90 days as presented on its landing-page evidence. Embody also promotes flat locked-in monthly pricing and no long-term commitment, with cancel anytime terms, but the supplied evidence frames Embody as a lean, low-cost program without the premium guarantees noted by Wellmedr.

Shipping speed and fulfillment commitments

Embody promises free shipping with delivery in 1 to 2 days after clinician approval and multiple mentions of fast delivery in the landing evidence. Wellmedr promotes same-day review plus free overnight shipping in its short bullets and landing-page captures and lists on-time refills guaranteed and discreet delivery as features.

Compounded medications and regulatory notice

Both providers offer compounded GLP-1 medications. Wellmedr explicitly states it offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies and includes the regulatory notice that compounded medications are not evaluated by the FDA for safety or efficacy. Embody also notes that its offerings are compounded and that compounded medications are not FDA-approved finished products. Both sources present the regulatory qualifier that compounded meds are not reviewed by FDA as supplied.

Comparison table

Criteria	Wellmedr	Embody
Starting price	Semaglutide from $89/month; 1-Year Plan mentioned	Semaglutide $69/month (was $299); Tirzepatide $119/month
Pricing model	Lifetime locked-in pricing; no dose-based price increases	Flat locked-in monthly pricing; no membership; cancel anytime
Promotions and guarantees	Labor Day sale messaging; money back guarantee claim for 90 days	$69 price noted as cut from $299; limited-time language present
Shipping speed	Same-day review plus free overnight shipping claimed	Free shipping; arrives in 1 to 2 days after approval
Medication type	Compounded GLP-1s; mentions Ozempic and Zepbound pricing in capture	Compounded semaglutide and tirzepatide only; no branded options noted
Regulatory notice	Compounded meds not evaluated by FDA for safety or efficacy	Compounded medications are not FDA-approved finished products

Clinical review, approvals, and stated limitations

Both platforms require clinician review and medical evaluation before treatment. Wellmedr explicitly notes that all treatment plans require medical evaluation and clinician approval and cautions that compounded medications are regulated by state Boards of Pharmacy but are not evaluated by the FDA for safety or efficacy. Embody likewise states prescriptions are issued after licensed provider review and that final pricing may vary based on dose and clinician recommendation.

Check Embody’s $69 semaglutide offer

User experience and support features

Embody positions itself for cost-driven patients who want a straightforward telehealth model with prescription and telemed visits included and 24/7 support for dosing and side-effect questions noted in the source. Wellmedr highlights features such as on-time refills guaranteed, discreet delivery, and promotional incentives for locking in reduced pricing. The supplied evidence does not include clinical outcome data specific to either provider beyond general references to published clinical research on GLP-1 medications.

Which provider fits your priorities

If price and fastest shipping are your top priorities, Embody advertises the lowest entry price for compounded semaglutide at $69/month and free 1 to 2 day delivery after approval. If locked pricing, dose stability, promotional guarantees, and explicit money back language matter more, Wellmedr highlights lifetime locked-in pricing, no dose-based price increases, same-day review plus free overnight shipping, and a money back guarantee claim for 90 days in its captured materials.

Compare Wellmedr plans now

Enroll with Wellmedr if you qualify

Final summary: Wellmedr vs Embody

Wellmedr vs Embody boils down to locked pricing and promotional guarantees versus the lowest advertised monthly price and rapid shipping. Both use compounded GLP-1 medications and require clinician review. Wellmedr emphasizes lifetime locked pricing and a 90 day money back claim in captured evidence. Embody emphasizes $69/month semaglutide, $119/month tirzepatide, and free 1 to 2 day shipping after approval.

Choose Wellmedr if you prioritize locked-in pricing, no dose-based increases, same-day review and the promotional guarantees captured in Wellmedr materials. Choose Embody if you prioritize the lowest advertised monthly price for compounded semaglutide and fastest shipping after clinician approval.